Carl Grunfeld

Author PubWeight™ 151.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004 4.67
2 Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005 4.02
3 Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010 2.71
4 Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS 2012 2.65
5 Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 2005 2.56
6 Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010 2.47
7 The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol 2006 2.44
8 Microalbuminuria in HIV infection. AIDS 2007 2.28
9 State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation 2008 2.17
10 Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr 2008 2.05
11 Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring) 2006 2.00
12 Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr 2002 1.98
13 Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr 2003 1.95
14 Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 2007 1.94
15 The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. J Acquir Immune Defic Syndr 2008 1.94
16 Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002 1.88
17 Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010 1.84
18 Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS 2002 1.79
19 Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr 2010 1.67
20 The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS 2004 1.64
21 Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects. Am J Clin Nutr 2008 1.63
22 Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism 2007 1.60
23 Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis 2011 1.48
24 Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 2004 1.44
25 Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine. J Acquir Immune Defic Syndr 2005 1.42
26 Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients. J Acquir Immune Defic Syndr 2004 1.39
27 Association of antiretroviral therapy with fibrinogen levels in HIV-infection. AIDS 2008 1.38
28 Repression of farnesoid X receptor during the acute phase response. J Biol Chem 2003 1.36
29 HIV viremia and changes in kidney function. AIDS 2009 1.32
30 LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. J Lipid Res 2008 1.30
31 Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 2003 1.27
32 Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr 2007 1.25
33 Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation 2008 1.24
34 Illicit drug use and HIV treatment outcomes in a US cohort. AIDS 2008 1.24
35 Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab 2007 1.24
36 Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 2002 1.20
37 The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab 2009 1.20
38 Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS 2011 1.19
39 Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. Am J Clin Nutr 2008 1.18
40 Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res 2005 1.18
41 What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 2004 1.18
42 Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis 2006 1.15
43 The acute phase response inhibits reverse cholesterol transport. J Lipid Res 2010 1.14
44 Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care 2011 1.13
45 Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 2002 1.13
46 Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. Clin Infect Dis 2002 1.11
47 Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS One 2009 1.09
48 Association of low level viremia with inflammation and mortality in HIV-infected adults. PLoS One 2011 1.09
49 A genome-wide association study of carotid atherosclerosis in HIV-infected men. AIDS 2010 1.08
50 Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS 2007 1.07
51 The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 2009 1.07
52 HIV therapy, metabolic syndrome, and cardiovascular risk. Curr Atheroscler Rep 2008 1.06
53 HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr 2004 1.06
54 Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS 2010 1.06
55 FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Endocrinology 2012 1.05
56 Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis 2007 1.05
57 Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. AIDS 2011 1.03
58 Inflammation stimulates the expression of PCSK9. Biochem Biophys Res Commun 2008 1.02
59 Urinary markers of kidney injury and kidney function decline in HIV-infected women. J Acquir Immune Defic Syndr 2012 1.01
60 Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. J Lipid Res 2006 1.00
61 The role of HDL in innate immunity. J Lipid Res 2010 0.98
62 Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol 2012 0.98
63 Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1). J Lipid Res 2006 0.98
64 Indinavir increases glucose production in healthy HIV-negative men. AIDS 2004 0.96
65 Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci 2011 0.96
66 Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 2004 0.96
67 HIV, inflammation, and calcium in atherosclerosis. Arterioscler Thromb Vasc Biol 2013 0.95
68 Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab 2010 0.94
69 Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. J Clin Endocrinol Metab 2012 0.92
70 The relationship between body mass index and mental health among Iraq and Afghanistan veterans. J Gen Intern Med 2013 0.92
71 Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons. Am J Clin Nutr 2005 0.92
72 Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm. J Lipid Res 2009 0.92
73 Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am J Physiol Endocrinol Metab 2004 0.91
74 ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists. Atherosclerosis 2009 0.91
75 The Effects of HIV Protease Inhibitors on Carbohydrate and Lipid Metabolism. Curr Infect Dis Rep 2004 0.90
76 Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes. J Biol Chem 2009 0.90
77 A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS 2014 0.89
78 Effect of inter-reader variability on outcomes in studies using carotid intima media thickness quantified by carotid ultrasonography. Eur J Epidemiol 2010 0.89
79 Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am J Physiol Endocrinol Metab 2006 0.89
80 Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans. AIDS 2013 0.89
81 LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2008 0.88
82 Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men. Pharmacogenet Genomics 2011 0.88
83 Suppression of estrogen-related receptor alpha and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response. J Lipid Res 2005 0.87
84 Parotid secretory protein is an HDL-associated protein with anticandidal activity. Am J Physiol Regul Integr Comp Physiol 2005 0.87
85 Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors. Am J Infect Dis 2006 0.87
86 Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue. Innate Immun 2011 0.87
87 The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009 0.86
88 Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum. J Acquir Immune Defic Syndr 2006 0.86
89 Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine. J Acquir Immune Defic Syndr 2008 0.86
90 Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. Am J Physiol Endocrinol Metab 2002 0.86
91 Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy. J Acquir Immune Defic Syndr 2009 0.85
92 Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease. BMC Nephrol 2011 0.85
93 HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection. AIDS 2014 0.84
94 Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals. Atherosclerosis 2013 0.84
95 Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis. J Lipid Res 2010 0.84
96 The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis 2004 0.83
97 Does HIV infection promote early kidney injury in women? Antivir Ther 2013 0.83
98 The effects of HIV protease inhibitors on carbohydrate and lipid metabolism. Curr HIV/AIDS Rep 2005 0.83
99 Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS 2015 0.83
100 HIV infection is associated with decreased thrombin generation. Clin Infect Dis 2012 0.83
101 The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. AIDS 2010 0.82
102 Lipids: a key player in the battle between the host and microorganisms. J Lipid Res 2012 0.82
103 Incidence and risk factors for acute kidney injury in HIV Infection. Am J Nephrol 2012 0.82
104 Angiopoietin like protein 4 expression is decreased in activated macrophages. Biochem Biophys Res Commun 2012 0.82
105 Association of increased upper trunk and decreased leg fat with 2-h glucose in control and HIV-infected persons. Diabetes Care 2011 0.81
106 The fatty liver in AIDS. Semin Gastrointest Dis 2002 0.81
107 Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. J Am Coll Cardiol 2013 0.81
108 Effect of inflammation on HDL structure and function. Curr Opin Lipidol 2016 0.81
109 Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS 2017 0.81
110 Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis. Rheumatology (Oxford) 2011 0.80
111 Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab 2015 0.80
112 Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM). Am J Nephrol 2011 0.80
113 Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta 2007 0.80
114 Ceramides stimulate caspase-14 expression in human keratinocytes. Exp Dermatol 2013 0.79
115 Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production. J Interferon Cytokine Res 2014 0.78
116 Intermuscular adipose tissue and metabolic associations in HIV infection. Obesity (Silver Spring) 2010 0.78
117 Leptin and the immunosuppression of malnutrition. J Clin Endocrinol Metab 2002 0.78
118 Fish oil for treatment of hypertriglyceridemia in HIV infection: fish or foul? Clin Infect Dis 2005 0.78
119 HIV protease inhibitors and glucose metabolism. AIDS 2002 0.77
120 Inflammation inhibits GPR81 expression in adipose tissue. Inflamm Res 2011 0.77
121 Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers. J Acquir Immune Defic Syndr 2010 0.77
122 Prevalence and factors associated with dry skin in HIV infection: the FRAM study. AIDS 2007 0.77
123 Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun 2010 0.76
124 Teriparatide treatment of osteoporosis in an HIV-infected man: a case report and literature review. AIDS 2015 0.76
125 Psoriasis: it's more than just the skin. J Lipid Res 2012 0.76
126 Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy. AIDS 2004 0.76
127 Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice. Biochem Biophys Res Commun 2002 0.76
128 Understanding the complications of antiretroviral drugs. Clin Infect Dis 2008 0.75
129 Tesamorelin. Nat Rev Drug Discov 2011 0.75
130 The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. J Acquir Immune Defic Syndr 2009 0.75
131 Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection. AIDS 2017 0.75
132 CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation. J Acquir Immune Defic Syndr 2017 0.75
133 Association of glucocorticoid receptor haplotypes with body composition and metabolic parameters in HIV-infected patients from the FRAM study. Pharmacogenet Genomics 2014 0.75